Rate of Progression in EYS Related Retinal Degeneration
Condition(s):Retinitis Pigmentosa; Eye DiseasesLast Updated:March 8, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Retinitis Pigmentosa; Eye DiseasesLast Updated:March 8, 2023Active, not recruiting
Condition(s):Primary Intestinal Hypocholesterolemia; Abetalipoproteinemia; Chylomicron Retention DiseaseLast Updated:September 21, 2023Recruiting
Condition(s):Retinal Degeneration; Retinitis PigmentosaLast Updated:April 5, 2018Completed
Condition(s):Retinitis Pigmentosa; Cone Dystrophy; Usher Syndromes; Retina; DystrophyLast Updated:June 19, 2019Recruiting
Condition(s):Retinitis Pigmentosa; Usher Syndrome Type 2; Deaf Blind; Retinal Disease; Eye Diseases; Eye Diseases, Hereditary; Eye Disorders Congenital; Vision DisordersLast Updated:January 20, 2023Terminated
Condition(s):Retinitis Pigmentosa; Retinal Diseases; Eye Diseases; Eye Disease, Hereditary; Retinal DegenerationLast Updated:April 14, 2016Completed
Condition(s):Leber Congenital Amaurosis 2; Retinitis Pigmentosa 20Last Updated:November 29, 2023Completed
Condition(s):Non-syndromic Retinitis PigmentosaLast Updated:July 26, 2022Recruiting
Condition(s):Retinitis Pigmentosa; Retinal Diseases; Retinal DegenerationLast Updated:June 9, 2021Completed
Condition(s):Retinitis Pigmentosa; Retinal DystrophyLast Updated:January 5, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.